GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » Capex-to-Revenue

Albert David (BOM:524075) Capex-to-Revenue : 0.00 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Albert David's Capital Expenditure for the three months ended in Jun. 2024 was ₹0.00 Mil. Its Revenue for the three months ended in Jun. 2024 was ₹893.56 Mil.

Hence, Albert David's Capex-to-Revenue for the three months ended in Jun. 2024 was 0.00.


Albert David Capex-to-Revenue Historical Data

The historical data trend for Albert David's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David Capex-to-Revenue Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.01 0.04 0.02 0.03

Albert David Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Albert David's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Albert David's Capex-to-Revenue falls into.



Albert David Capex-to-Revenue Calculation

Albert David's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-108.74) / 3602.625
=0.03

Albert David's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 893.564
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David  (BOM:524075) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Albert David Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Albert David's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David Headlines

No Headlines